Everything You Need Before Starting TRT.
Lab guides, treatment comparisons, dosing protocols, and honest clinic reviews. Built for people doing their homework.
For informational purposes only. Not medical advice.
Your TRT Journey
From “is this low T?” to the right clinic — we’ll walk you through it.
Latest Articles
Newest guides, explainers, and research breakdowns.
Acrux Advances Female Testosterone to Phase 3 for HSDD
On April 30, 2026, Acrux announced Phase 3 trials for a transdermal female testosterone product for HSDD. Here is what it means and what is available now.
Blood Test Flags Combined HRT Dementia Risk in Some
March 2026 JAMA study: high p-tau217 plus combined HRT linked to 4x dementia risk. What it means if you are on or considering hormone therapy.
T:E2 Ratio on TRT: Target 12-22 for Libido & Mood
Why your testosterone-to-estradiol ratio predicts libido and erections better than either number alone. Target ranges, math, and protocol fixes.
TRT and Blood Pressure: What the Data Shows
What TRAVERSE, ambulatory BP studies, and the FDA's 2025 label change show about TRT and blood pressure — plus how disciplined clinics monitor it.
HRT and Breast Cancer Risk: What WHI Got Wrong
Estrogen-only HRT cuts breast cancer mortality 40%. Combination HRT adds 1 case per 50-200 women. The real numbers behind the WHI scare.
European TRT Verdict: AFib Signal, Heart Safety
Europe's testosterone expert panel issued its 2026 TRAVERSE verdict. Heart attacks reassuring, atrial fibrillation signal real. What changes for you.
Our clinic evaluations use an 8-dimension scoring methodology covering diagnostics, monitoring, protocols, physician quality, pricing, telehealth, medication access, and transparency.